Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
>VIRxSYS corporation is a private biotech company whose mission is to develop gene therapies using its proprietary lentiviral vector delivery system. The company is in Phase II clinical trials testing the first application of its gene therapy technology against HIV, VRX496. VIRxSYS also has collaborations for therapies in certain cancers and genetic diseases. The ability to safely and efficiently deliver genetic therapies has long been an obstacle to successful gene therapy, but VIRxSYS’s lentiviral vector is designed to deliver on the promise of genetic medicine. The Company expects that its genetic medicines will provide dramatically improved patient outcomes, including disease remission and may, possibly, provide permanent ( www.virxsys.com )
VIRxSYS Corporation
200 Perry Parkway Suite 1A
Gaithersburg, Maryland 20877
USA
Tel: (301) 987-0480
Fax: (301) 987-0489